OMRNF(OMRNF)
OMRNF
No analyst ratings available
No analyst price targets available for OMRNF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $892.05B | $945.66B | $976.64B | $980.06B | $1.02T |
| Low | $868.26B | $903.30B | $941.47B | $944.76B | $983.72B |
| High | $915.91B | $985.98B | $1.01T | $1.01T | $1.06T |
| EBITDA Avg | $100.46B | $125.76B | $135.13B | $120.37B | $134.10B |
| Low | $97.50B | $121.76B | $130.83B | $116.87B | $130.07B |
| High | $103.33B | $129.64B | $139.30B | $123.76B | $138.02B |
| EBIT Avg | $63.25B | $85.37B | $91.84B | $74.73B | $86.13B |
| Low | $60.29B | $81.37B | $87.54B | $71.23B | $82.10B |
| High | $66.12B | $89.25B | $96.01B | $78.13B | $90.04B |
| Net Income Avg | $49.97B | $67.44B | $72.55B | $59.04B | $68.04B |
| Low | $47.63B | $64.28B | $69.16B | $56.27B | $64.86B |
| High | $52.24B | $70.50B | $75.85B | $61.72B | $71.13B |
| EPS Avg | $253.97 | $342.79 | $368.79 | $300.08 | $345.85 |
| Low | $242.08 | $326.74 | $351.52 | $286.03 | $329.66 |
| High | $265.51 | $358.36 | $385.54 | $313.71 | $361.56 |
| Analysts (Rev / EPS) | 7 / 1 | 10 / 1 | 5 / 1 | 5 / 1 | 4 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 |
|---|---|---|---|---|
| Revenue Avg | $214.45B | $221.43B | $255.52B | $226.22B |
| Low | $212.39B | $221.29B | $254.24B | $225.08B |
| High | $216.51B | $221.56B | $256.81B | $227.35B |
| EBITDA Avg | $9.58B | $27.18B | $37.89B | $29.80B |
| Low | $9.56B | $27.08B | $37.72B | $29.68B |
| High | $9.59B | $27.28B | $38.07B | $29.92B |
| EBIT Avg | $-1.42B | $16.12B | $26.67B | $18.50B |
| Low | $-1.43B | $16.01B | $26.49B | $18.38B |
| High | $-1.40B | $16.22B | $26.84B | $18.62B |
| Net Income Avg | $-1.83B | $12.40B | $20.74B | $14.29B |
| Low | $-1.84B | $12.32B | $20.60B | $14.19B |
| High | $-1.82B | $12.48B | $20.87B | $14.38B |
| EPS Avg | $-9.32 | $63.08 | $105.46 | $72.66 |
| Low | $-9.38 | $62.67 | $104.77 | $72.18 |
| High | $-9.25 | $63.49 | $106.15 | $73.13 |
| Analysts (Rev / EPS) | 3 / 1 | 3 / 1 | 1 / 1 | 1 / 1 |